Application no. and date | 20213929.1 (espacenet) (Federated) (European Patent Register), 20160803 | Patent/reg. no. and date | DK/EP 3822262, 20240327 | Publication date | 20210519 | Priority no. and date | GB 201513742, 20150803 | EP pub. no. and date |
EP 3822262 20210519 | Effective date | | Applicant/owner | | Applicant ref. no. | | Inventor | CONGREVE, Miles Stuart, c/o Heptares Therapeutics Limited Granta Park Great Abington
Cambridge, CB21 6DG, GB, BROWN, Giles Albert, c/o Heptares Therapeutics Limited Granta Park Great Abington
Cambridge, CB21 6DG, GB, TEHAN, Benjamin Gerald, c/o Heptares Therapeutics Limited Granta Park Great Abington
Cambridge, CB21 6DG, GB, PICKWORTH, Mark, c/o Heptares Therapeutics Limited Granta Park Great Abington
Cambridge, CB21 6DG, GB | Representative | | Opponent | | IPC Class | A61P 25/00 (2006.01) , A61P 25/02 (2006.01) , A61P 25/04 (2006.01) , A61P 25/14 (2006.01) , A61P 25/18 (2006.01) , A61P 25/28 (2006.01) , A61P 25/30 (2006.01) , A61P 29/00 (2006.01) , A61P 43/00 (2006.01) , C07D 401/04 (2006.01) , C07D 401/08 (2006.01) | Title | MUSCARINIC AGONISTS | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|